Literature DB >> 20884985

The use of minimally invasive techniques in multi-level surgery for children with cerebral palsy: preliminary results.

N Thompson1, J Stebbins, M Seniorou, A M Wainwright, D J Newham, T N Theologis.   

Abstract

This study compares the initial outcomes of minimally invasive techniques for single-event multi-level surgery with conventional single-event multi-level surgery. The minimally invasive techniques included derotation osteotomies using closed corticotomy and fixation with titanium elastic nails and percutaneous lengthening of muscles where possible. A prospective cohort study of two matched groups was undertaken. Ten children with diplegic cerebral palsy with a mean age of ten years six months (7.11 to 13.9) had multi-level minimally invasive surgery and were matched for ambulatory level and compared with ten children with a mean age of 11 years four months (7.9 to 14.4) who had conventional single-event multi-level surgery. Gait kinematics, the Gillette Gait Index, isometric muscle strength and gross motor function were assessed before and 12 months after operation. The minimally invasive group had significantly reduced operation time and blood loss with a significantly improved time to mobilisation. There were no complications intra-operatively or during hospitalisation in either group. There was significant improvement in gait kinematics and the Gillette Gait Index in both groups with no difference between them. There was a trend to improved muscle strength in the multi-level group. There was no significant difference in gross motor function between the groups. We consider that minimally invasive single-event multi-level surgery can be achieved safely and effectively with significant advantages over conventional techniques in children with diplegic cerebral palsy.

Entities:  

Mesh:

Year:  2010        PMID: 20884985     DOI: 10.1302/0301-620X.92B10.24307

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  7 in total

Review 1.  [Bilateral spastic cerebral palsy with ambulatory ability (diplegia): pathophysiology, state of the art of conservative and surgical treatment and rehabilitation].

Authors:  B Westhoff; D Bittersohl; R Krauspe
Journal:  Orthopade       Date:  2014-07       Impact factor: 1.087

2.  Effects of minimally invasive surgery and functional physiotherapy on motor function of children with cerebral palsy: A non-randomised controlled trial.

Authors:  Vasileios C Skoutelis; Anastasios D Kanellopoulos; Stamatis G Vrettos; Zacharias Dimitriadis; Efstratia Kalamvoki; Argirios Dinopoulos; Panayiotis J Papagelopoulos; Stefanos S Vrettos; Vasileios A Kontogeorgakos
Journal:  J Orthop       Date:  2021-09-14

3.  Percutaneous Versus Open Hamstring Lengthening in Spastic Diplegic Cerebral Palsy.

Authors:  Javad Khaje Mozafari; Karim Pisoudeh; Kave Gharanizade; Mansour Abolghasemian
Journal:  Arch Bone Jt Surg       Date:  2019-07

Review 4.  A Systematic Review of the Effects of Single-Event Multilevel Surgery on Gait Parameters in Children with Spastic Cerebral Palsy.

Authors:  Robert P Lamberts; Marlette Burger; Jacques du Toit; Nelleke G Langerak
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

Review 5.  What is the functional mobility and quality of life in patients with cerebral palsy following single-event multilevel surgery?

Authors:  Tomos Aled Edwards; Robin John Prescott; Julie Stebbins; James Wright; Tim Theologis
Journal:  J Child Orthop       Date:  2020-04-01       Impact factor: 1.548

6.  Is percutaneous proximal gracilis tenotomy as effective and safe as the open procedure?

Authors:  Bilal Hachache; Tony Eid; Elias Ghosn; Amer Sebaaly; Khalil Kharrat; Ismat Ghanem
Journal:  J Child Orthop       Date:  2015-10-26       Impact factor: 1.548

Review 7.  Ankle Dorsiflexor Function after Gastrocsoleus Lengthening in Children with Cerebral Palsy: A Literature Review.

Authors:  Nicholas Sclavos; Norine Ma; Elyse Passmore; Pam Thomason; H Kerr Graham; Erich Rutz
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.